Skip to content
★ Sign in to follow
DM

Dugan Margaret Han

Executive
Insider activity · 24 months0 buys1 saleCumulative net flow
Total declarations
11
Company
1
▲ Purchases (6 ops.)
—
▼ Sales (1 ops.)
€7,211

Latest filing published 16 Jun 2026 for BeOne Medicines Ltd..

Filing timeline

BuySale
Dugan Margaret Han

Insider track record

Disclosed buys
6
Disclosed sells
1
Signal history

No signal scores available.

Closed purchases

Market purchases
6

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 16 Jun 2026 · 146 days ago
    +40.9%
    Entry US$262.68 · Close 19 Oct 2026 US$370.17

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Dugan Margaret Han: trading record in brief

Dugan Margaret Han appears in 11 filings at BeOne Medicines Ltd., published from March 3, 2022 to June 16, 2026, as a director. The record is almost entirely on the buying side: 6 purchases, or 86% of the open-market trades, against a single sale of EUR 7,211 on May 22, 2026, the only selling trade in the record. Four other filings are of another kind, and BeOne is the only issuer in the record.

The yearly pace is 2 filings a year from 2022 to 2025, then 3 in 2026, the maximum of the record. Three filings fall in the last twelve months, including one purchase and the May 2026 sale. The median publication delay is 5 days.

The count of trades by Han within 30 days of colleagues at BeOne Medicines Ltd. is 7, 6, 6, 6 and 6. Of which in the same direction: 7, 6, 5, 5 and 5. Names in order: Riva Alessandro, Oyler John Victor, Goller Michael John, Hooper Anthony Campbell and Krishana Ranjeev.

Companies and markets linked to Dugan Margaret Han

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations11 total

11 of 11 declarations